within Pharmacolibrary.Drugs.ATC.M;

model M03AA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 8.999999999999999e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00019,
    k12             = 0.023,
    k21             = 0.023
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M03AA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Alcuronium is a non-depolarizing neuromuscular blocking agent formerly used as an adjunct to general anesthesia in order to facilitate endotracheal intubation and relaxation of skeletal muscles during surgery. It has largely been replaced by newer agents and is not commonly used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adults after intravenous administration. No original literature with detailed PK parameters identified; values are based on secondary sources and pharmacology textbooks.</p><h4>References</h4><ol><li><p>Walker, J, et al., &amp; Triggs, EJ (1980). Clinical pharmacokinetics of alcuronium chloride in man. <i>European journal of clinical pharmacology</i> 17(6) 449–457. DOI:<a href=&quot;https://doi.org/10.1007/BF00570163&quot;>10.1007/BF00570163</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7398736/&quot;>https://pubmed.ncbi.nlm.nih.gov/7398736</a></p></li><li><p>Diefenbach, C, et al., &amp; Theisohn, M (1995). Alcuronium: a pharmacodynamic and pharmacokinetic update. <i>Anesthesia and analgesia</i> 80(2) 373–377. DOI:<a href=&quot;https://doi.org/10.1097/00000539-199502000-00029&quot;>10.1097/00000539-199502000-00029</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7818127/&quot;>https://pubmed.ncbi.nlm.nih.gov/7818127</a></p></li><li><p>Miller, RS, et al., &amp; Möller, C (1997). Effect of cardiopulmonary bypass on the plasma concentrations of fentanyl and alcuronium. <i>Journal of clinical pharmacy and therapeutics</i> 22(3) 197–205. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2710.1997.94875948.x&quot;>10.1046/j.1365-2710.1997.94875948.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9447475/&quot;>https://pubmed.ncbi.nlm.nih.gov/9447475</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M03AA01;
